Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the page, linking to transition updates and describing a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T01:48:03.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T01:55:07.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T01:50:40.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The study page now displays a 403 error with a Home button, replacing the previous study details and related information.
    Difference
    16%
    Check dated 2026-09-26T01:51:56.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with standard header/footer, replacing the previous detailed study record content and metadata.
    Difference
    16%
    Check dated 2026-09-19T01:08:56.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now shows No longer looking for participants and lists 226 study locations (down from 264). It also updates the primary completion date to 2026-08-10 and the study completion date to 2027-09-08, with a protocol revision noted as Revision: v3.6.6.
    Difference
    6%
    Check dated 2026-08-28T18:46:54.000Z thumbnail image

Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.